Relay Therapeutics Inc is trading 4.9% down at $13.84 amid broader risk-off pressure in growth and biotech names following a stronger-than-expected jobs report.
- The move extends a pullback from a sharp price jump recorded on June 2, 2026.
- There are no new company-specific press releases, trial updates, or analyst calls reported this morning.
- The decline aligns with a wider downturn in major U.S. indices as investors react to rising interest rate concerns.